Healthcare supplement listed companies, page-2

This positive trend for listed supplements and vitamins companies is a surprise.
At the beginning of 2023, the 2 leaders (Blackmore and Swisse) were cautious about the Australian market, both expecting a slowdown, due to the cost of living pressures.

I see 3 possible explanations for the good trend now for EZZ,BIO and VLS :
- they are much smaller companies* than the 2 leaders (ex.Blackmore sales are estimated to be 10x Vita sales),
- EZZ and Bio are still very recent companies,
- the 3 companies benefit from their rapid expansion out of Australia.

* in FY 23, Swisse had global sales of 1 bn AUD vs 37 m AUD for EZZ, 8 m AUD for Biome and 74 m AUD for Vita Life Sciences.